HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lauren C Harshman Selected Research

Gemcitabine

8/2015Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
12/2010Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lauren C Harshman Research Topics

Disease

37Neoplasms (Cancer)
01/2023 - 01/2009
36Renal Cell Carcinoma (Grawitz Tumor)
01/2023 - 12/2007
18Prostatic Neoplasms (Prostate Cancer)
03/2024 - 08/2013
15Neoplasm Metastasis (Metastasis)
03/2024 - 05/2014
14Carcinoma (Carcinomatosis)
12/2021 - 01/2009
10Urinary Bladder Neoplasms (Bladder Cancer)
12/2020 - 08/2014
3Kidney Neoplasms (Kidney Cancer)
01/2023 - 11/2017
3Disease Progression
01/2021 - 01/2009
3Fatigue
01/2020 - 06/2018
3Melanoma (Melanoma, Malignant)
01/2017 - 08/2014
2Inflammation (Inflammations)
12/2020 - 06/2014
2Urologic Neoplasms (Urological Cancer)
10/2020 - 10/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2014 - 05/2014
1Brain Neoplasms (Brain Tumor)
12/2021
1Adenocarcinoma
10/2019
1Residual Neoplasm
10/2019
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2019
1Pathologic Complete Response
01/2019
1Lymphatic Metastasis
01/2019
1Vasculitis (Vasculitides)
01/2019
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2019
1Venous Thromboembolism
10/2017
1Hematologic Neoplasms (Hematological Malignancy)
01/2017

Drug/Important Bio-Agent (IBA)

11Immune Checkpoint InhibitorsIBA
01/2021 - 01/2017
9Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2009
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018 - 10/2009
8AndrogensIBA
01/2021 - 08/2013
6PlatinumIBA
12/2021 - 01/2009
6Cisplatin (Platino)FDA LinkGeneric
01/2021 - 05/2014
6Hormones (Hormone)IBA
12/2020 - 09/2010
4Bevacizumab (Avastin)FDA Link
01/2023 - 10/2010
4cabozantinibIBA
12/2021 - 06/2018
4Abiraterone AcetateIBA
01/2021 - 08/2013
4B7-H1 AntigenIBA
01/2021 - 07/2014
4Docetaxel (Taxotere)FDA Link
12/2020 - 01/2009
4Hemoglobins (Hemoglobin)IBA
11/2018 - 10/2009
4Prostate-Specific Antigen (Semenogelase)IBA
11/2018 - 06/2014
3atezolizumabIBA
01/2023 - 01/2020
3CytokinesIBA
12/2020 - 06/2014
3Androgen Receptors (Androgen Receptor)IBA
12/2020 - 11/2017
3abirateroneIBA
10/2019 - 08/2013
3Sunitinib (Sutent)FDA Link
11/2018 - 06/2009
2Radium-223IBA
03/2024 - 01/2018
2pembrolizumabIBA
03/2024 - 01/2019
2Prednisone (Sone)FDA LinkGeneric
01/2021 - 10/2019
2IpilimumabIBA
12/2020 - 08/2014
2enzalutamideIBA
12/2020 - 10/2019
2Interleukin-8 (Interleukin 8)IBA
12/2020 - 06/2014
2Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2014
2Cell-Free Nucleic AcidsIBA
11/2018 - 11/2017
2pazopanibFDA Link
11/2018 - 01/2018
2EverolimusFDA Link
01/2018 - 06/2013
2LigandsIBA
01/2018 - 07/2014
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2017 - 07/2015
2Monoclonal AntibodiesIBA
01/2017 - 08/2014
2thiamine triphosphorate (TTP)IBA
02/2016 - 07/2015
2GemcitabineFDA Link
08/2015 - 12/2010
2TOR Serine-Threonine KinasesIBA
10/2014 - 06/2013
2Tyrosine Kinase InhibitorsIBA
04/2013 - 02/2013
1sacituzumab govitecanIBA
12/2021
1enfortumab vedotinIBA
12/2021
1erdafitinibIBA
12/2021
1Bone Density Conservation AgentsIBA
01/2021
1NivolumabIBA
12/2020
1CrizotinibIBA
12/2020
1Purinergic P1 Receptors (Adenosine Receptor)IBA
11/2020
15'-Nucleotidase (5' Nucleotidase)IBA
11/2020
1CD39 antigenIBA
11/2020
1Anti-Bacterial Agents (Antibiotics)IBA
01/2020
1NucleotidesIBA
01/2020
1taxaneIBA
01/2020
1Therapeutic UsesIBA
10/2019
1Leuprolide (Lupron)FDA LinkGeneric
10/2019
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
10/2019
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2019
1Alkaline PhosphataseIBA
11/2018
1TFXIBA
11/2018
1Sorafenib (BAY 43-9006)FDA Link
11/2018
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2018
1Phosphotransferases (Kinase)IBA
01/2018
1Tyrosine (L-Tyrosine)FDA Link
01/2018
1Radioisotopes (Radionuclides)IBA
11/2017
1Interleukin-2 (IL2)IBA
11/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2015

Therapy/Procedure

42Therapeutics
01/2023 - 01/2009
12Drug Therapy (Chemotherapy)
12/2021 - 08/2013
11Castration
03/2024 - 08/2013
7Immunotherapy
01/2023 - 08/2014
7Cystectomy
12/2020 - 08/2015
4Adjuvant Chemotherapy
12/2020 - 01/2018
4Nephrectomy
11/2018 - 12/2007
3Neoadjuvant Therapy
10/2020 - 08/2015
3Chemoradiotherapy
04/2018 - 12/2014
2Combination Drug Therapy (Combination Chemotherapy)
12/2021 - 10/2019
2Drug Tapering
01/2020 - 06/2018
1Urinary Diversion (Ileal Conduit)
12/2020
1Prostatectomy (Retropubic Prostatectomy)
10/2019
1Lymph Node Excision (Lymph Node Dissection)
01/2019
1Re-Irradiation
04/2017
1Radiotherapy
04/2017